Keywords
Abstract
Ushbu maqolada pnevmoniya kasalligini davolashda zamonaviy farmakologik yondashuvlar tahlil qilinadi. An’anaviy antibiotiklarga nisbatan bakteriyalarning qarshilik darajasi ortib borayotgani sharoitida yangi avlod dori vositalari, biologik preparatlar va individualizatsiyalangan terapiya usullarining roli alohida ko‘rib chiqilgan. Tadqiqotda ko‘rsatib o‘tilishicha, pnevmoniya davolashda nafaqat keng spektrli antibiotiklar, balki immunomodulyatorlar, fagoterapiya, va nanodori yetkazish tizimlarining qo‘llanilishi kasallik kechishini yengillashtirishga va retsidivlarning oldini olishga yordam bermoqda. Shuningdek, maqolada antibiotiklarga chidamli shtammlarga qarshi kurashish bo‘yicha xalqaro strategiyalar va ularning klinik amaliyotga tatbiq etilishi yoritilgan.
References
1. World Health Organization (2023). "Pneumonia Fact Sheet". www.who.int
2. Wunderink RG, Waterer GW. (2017). "Advances in the treatment of community-acquired pneumonia". Current Opinion in Pulmonary Medicine.
3. File TM, Marrie TJ. (2020). "New antibiotics and the management of pneumonia". Clinical Chest Medicine.
4. Fischetti VA, et al. (2016). Phage Therapy: Past, Present and Future. Springer.
5. Kollef MH et al. (2021). "New antibiotics and treatment strategies for multidrug-resistant pathogens in pneumonia". Critical Care Medicine.
6. Mehta M et al. (2022). "Nanoparticle drug delivery systems in respiratory infections". Journal of Controlled Release.
7. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi ma’lumotlari – www.minzdrav.uz
8. Ibragimov S. (2023). "Pnevmoniya va antibiotiklarga chidamlik: O‘zbekistonda yangi yondashuvlar". Tibbiyot va farmatsiya, №2.